18.08.2015 15:32:00
|
Moody's: US medical devices outlook brightens on M&A synergies, new products and admission trends
New York, August 18, 2015 -- The US medical products and devices industry will see solid EBITDA growth over the next 12 to 18 months, driven by large M&A deals, new products and an uptick in growth of hospital admissions, says Moody's Investors Service. The rating agency has revised its outlook to positive from stable on the industry.